Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Juniper Pharmaceuticals- Inc. (JNP)

8.725 -0.025 (-0.29%)

06-20 10:53

Open:

8.75

Pre. Close:

8.75

High:

8.8

Low:

8.725

Volume:

3,680

Market Cap:

97M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.821 - 8.879

8.879 - 8.932

Low:

8.455 - 8.53

8.53 - 8.597

Close:

8.635 - 8.752

8.752 - 8.859

Technical analysis  (as of: 2018-06-20 10:26:06 AM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 10.57     One year: 11.21

Support:

Support1: 8.15    Support2: 6.78

Resistance:

Resistance1: 9.05    Resistance2: 9.60

Pivot:

8.96

Moving Averages:

MA(5): 8.78     MA(20): 8.92

MA(100): 9.17     MA(250): 6.63

MACD:

MACD(12,26): -0.01     Signal(12,26,9): 0.02

%K %D:

%K(14,3): 26.52     %D(3): 28.40

RSI:

RSI(14): 47.25

52-Week:

High: 13.25  Low: 4.3  Change(%): 58.1

Average Vol(K):

3-Month: 8212  10-Days 3841

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
JNP has closed above bottom band by 31.5%. Bollinger Bands are 63.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to JNP's normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-10T13:28:04-04:00
Juniper Pharmaceuticals' (JNP) CEO Alicia Secor on Q1 2018 Results - Earnings Call Transcript

2018-05-10T07:04:45-04:00
Juniper Pharmaceuticals beats by $0.04, beats on revenue

2018-05-10T07:00:00-04:00
Juniper Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results

2018-05-01T07:00:00-04:00
Juniper Pharmaceuticals to Report First Quarter 2018 Results on May 10, 2018

2018-04-25T11:19:30-04:00
Daré Bioscience in-licenses contraceptive ring from Juniper Pharma; shares up 52%

2018-04-25T08:00:00-04:00
Juniper Pharmaceuticals Licenses Intravaginal Ring (IVR) Platform to Daré Bioscience

2018-04-19T13:34:00-04:00
Juniper Pharmaceuticals: Undervalued With Double-Digit Revenue Growth

2018-03-29T13:10:18-04:00
Midday Gainers / Losers (3/29/2018)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

11.10

Shares Float (M)

9.00

% Held by Insiders

% Held by Institutions

33.80

Shares Short (K)

166

Shares Short Prior Month (K)

99

Stock Financials

EPS

0.060

EPS Est. Current Year

-0.460

EPS Est. Next Year

0.150

EPS Est. Next Quarter

-0.120

Forward EPS

1.321

Book Value (p.s.)

1.940

PEG Ratio

Profit Margin

0.28

Operating Margin

-6.18

Return on Assets (ttm)

0.9

Return on Equity (ttm)

1.3

Qtrly Rev. Growth

-43.7

Gross Profit (p.s.)

1.043

Sales Per Share

EBITDA (p.s.)

-0.064

Qtrly Earnings Growth

-87.90

Operating Cash Flow (M)

2.13

Levered Free Cash Flow (M)

-0.90

atoplab.com

Valuation

P/E

146.29

P/E Growth Ratio

P/BV

4.52

P/S

21088318.00

P/CF

45.75

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-08-09

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.